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Summary
Introduction: Assessment of cerebral hemodynamics with transcranial Doppler (TCD) can pro-
vide real-time, bed-side assessment of important prognostic variables in acute stroke such as the
status of collateral ﬂow and vessel recanalization status. In acute middle cerebral artery (MCA)
occlusion, anterior cerebral artery (ACA) ﬂow diversion (FD) is correlated with leptomeningeal
collateral ﬂow and may be a clinically useful prognostic indicator. Continuous TCD monitor-
ing of MCA recanalization may also provide useful prognostic information including changes in
ﬂow pattern and the occurrence of microembolic signals (MES). We present studies examining
associations between ACA FD, MCA recanalization and MES patterns on the characteristics of
ischemia and infarction in acute MCA stroke.
Methods: Patients studied were consecutive sub-6 h from onset internal carotid artery (ICA) ter-
ritory ischemic stroke cases. A subset of these cases with MCA occlusion were studied with 2 h of
continuous MCAmonitoring. All patients underwent baseline multimodal computed tomographic
(CT) scanning, baseline diagnostic TCD, and 24 h post stroke magnetic resonance (MR) imaging.
All MCA occlusion patients studied with continuous monitoring were treated with intravenous
thrombolysis. ACA ﬂow diversion was deﬁned as ipsilateral mean velocity of 30% or greater than
the contralateral artery. Recanalization status was assessed using the Thrombolysis In Brain
ischemic (TIBI) grading system and MES counted ‘‘off-line’’ by experienced observers. Lep-
tomeningeal collateralisation (LMC) was graded on CT angiography. Infarct core and penumbral
volumes were deﬁned using CT perfusion thresholds. Infarct volume, reperfusion, and vessel
status were measured at 24 h using MR techniques. In patients undergoing recanalization moni-
toring, comparison was made between those with and without major reperfusion. Multivariable
regression analysis was performed to assess for any associations between ACA ﬂow diversion,
TIBI grades and MES on infarction controlling for other important clinical variables.
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Results: Flow diversion: 53 patients qualiﬁed for FD analysis. ACA FD was associated with good
collateral ﬂow on CT angiography (p < 0.001) and was an independent predictor of admission
infarct core volume (p < 0.001), and 24 h infarct volume (p < 0.001). The likelihood of a favourable
outcome (modiﬁed Rankin score 0—2) was higher (Odds ratio = 27.5, p < 0.001) in those with ﬂow
diversion.
Recanalization monitoring: 27 patients with MCA occlusion treated with intravenous thrombolysis
were included in the analysis of recanalization patterns (16 cases with major reperfusion, 11 cases
of non-reperfusion). Major TIBI grade improvement (≥ 3 grades overall) was associated with
major reperfusion (p = 0.04) excellent 90 day clinical outcome (p = 0.03), improvement in clinical
outcome at 24 h (p = 0.049) and attenuated infarct growth (p = 0.06). MES did not associate with
reperfusion status or outcome variables.
Conclusions: ACA FD is independently associated with the smaller infarction volumes and more
favourable 90 day clinical outcome. Flow diversion may provide enhanced perfusion of ischemic
tissue, offering some protection against infarct expansion and ‘‘buying-time’’ for effective reper-
fusion and tissue salvage.
Major TIBI grade improvement associates with major reperfusion, favourable 24 h and 90 day clin-
ical outcomes along with a trend to smaller infarct volumes in patients treated with intravenous
thrombolysis.
Acute bedside transcranial Doppler assessment of ACA FD and recanalization aids prognostication
king in acute stroke.
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eperfusion therapies in acute ischemic stroke are becoming
oth more widely used and more varied. In routine clini-
al practice, intravenous thrombolysis is generally regarded
s ‘‘ﬁrst-line’’ therapy and is being delivered to over
0% of ischemic stroke patients in many centers [1].
dvances in endovascular therapies, in particular, the var-
ous mechanical thrombectomy techniques [2,3], are being
ncreasingly applied and, although generally regarded as
‘second-line’’ treatment options based on the limited ran-
omised evidence, have signiﬁcant potential advantages
ver intravenous thrombolysis. With this increase in ther-
peutic options comes a need for development of validated
ethods for both selection of patients for speciﬁc thera-
ies and also, the identiﬁcation of patients not responding
o intravenous thrombolysis. Advanced MR and CT imag-
ng are well suited to guide initial patient selection for
eperfusion therapy. Both techniques can provide informa-
ion on the characteristics of vessel occlusion, collateral
ow and the extent of both hypoperfusion and established
nfarction [4,5]. Both techniques have been used in ran-
omised clinical trials and are now commonly used in routine
linical practice to identify likely ‘‘responders’’ to reperfu-
ion therapy [6]. However, imaging methods for identifying
‘non-responders’’ to intravenous thrombolysis have been
ess well studied and currently no well validated or generally
ccepted approach exists.
Transcranial Doppler is well suited to the task of iden-
ifying both collateralisation and the time course and
ompleteness of recanalization of the arteries of the circle
f Willis [7]. Numerous studies [8] have examined charac-
eristics and patterns of recanalization and its association
ith early neurological improvement. Recent advances in
ultimodal CT and MR imaging now allow more detailed
nvestigation and understanding of the potential role for TCD
n guiding acute stroke therapy, where correlation is possi-
le between important TCD characteristics and important
P
T
cH.
linical surrogates such as reperfusion and infarct core
rowth.
Leptomeningeal collateralisation (LMC) is a recognised
eterminant of tissue fate in patients with acute ante-
ior circulation ischemic stroke [9—14]. The status of LMC
s measured on catheter angiography in middle cerebral
rtery occlusion (MCAO) has been shown to inﬂuence brain
erfusion and clinical outcomes [12,15]. Collateral ﬂow
n MCAO measured using CT angiography (CTA) has been
emonstrated to inﬂuence the volume of ischemic penum-
ra measured on CT perfusion (CTP) and clinical outcome
16]. In MCA occlusion, ﬂow is commonly diverted from the
istal internal carotid artery (ICA) to the ACA [11,17—20].
his ﬂow diversion (FD) can be detected using TCD, where
ypically, a higher velocity ﬂow in the ipsilateral ACA can be
easured as compared with that of the contralateral ACA
17,20—24]. A retrospective review of data of patients with
proximal MCA occlusion from the CLOTBUST trial demon-
trated that ACA FD was associated with earlier and better
eurological improvement, supporting the hypothesis that
D may provide nutrient ﬂow to the ischemic brain [23].
To further clarify the potential clinical role for TCD in
electing patients for reperfusion therapies we investigated
. The relationship between ACA-FD on TCD, LMC status
on CTA, and measures of the acute perfusion lesion and
extent of infarction.
. The relationship between TCD features of recanalization
and major reperfusion, infarct growth attenuation and
clinical outcomes.
Open access under CC BY-NC-ND license.atients
he overall study population is a prospective cohort of
onsecutive TCD examinations in acute anterior circulation
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ischemic stroke patients presenting within 6 h of symptom
onset. The cohort was collected between June 2007 and
January 2010. Eligibility criteria were presence of a demon-
strated occlusion of either MCA or ICA on baseline acute CTA
in a patient undergoing assessment for potential suitability
for intravenous thrombolytic therapy. A subgroup of patients
with MCA occlusion and baseline TIBI grades ≤3 treated with
intravenous thrombolysis was used to study recanalization
features and MES characteristics. Patients were excluded if
a pre-morbid Rankin score (mRS) was greater than 3 or seri-
ous co-morbid illness limited the patient’s life expectancy,
if posterior circulation stroke was suspected, of tempo-
ral acoustic windows were inadequate, if unilateral ACA
hypoplasia or aplasia was evident on CTA (dominant ACA
at least twice the size of the contralateral ACA [25,26]).
Stroke severity was measured using the National Institutes
of Health Stroke Scale (NIHSS). Patient outcome was deter-
mined using the NIHSS at 24 h from stroke onset modiﬁed
Rankin scale at 90 days blind to imaging data. The study was
approved by the institutional ethics committee and individ-
ual patient consent was obtained.
Baseline TCD examination
TCD ultrasound was performed using a digital power-motion
Doppler unit (PMD 100, Spencer Technologies) with 2-MHz
pulsed wave diagnostic transducers. The initial TCD exami-
nation was performed immediately prior to commencement
of intravenous t-PA, or immediately following CT scanning
in the case of those not eligible for thrombolysis. The
insonation protocol was as follows: initially the non-affected
MCA was insonated from a depth of 60—45mm as a unidi-
rectional signal towards the probe. This included M1 and
M2 segments to determine the depths and velocity ranges
and continued to bifurcation, terminal ICA (TICA), ACA and
PCA. The proximal ACA waveform was determined from a
depth of 60—70mm as a unidirectional signal away from the
probe. Next, the affected MCA waveform was determined
and then the bifurcation, TICA, ACA and PCA. Flow mea-
surements for ACA FD were taken at ACA A1 segment (depth
60—70mm) as a ﬂow away from the probe. The ophthalmic
arteries (depths: 40—50mm) and ICA siphons (55—65mm)
were then checked for ﬂow direction and pulsatility through
the transorbital windows bilaterally [27].
Peak systolic, diastolic and mean ﬂow velocities and pul-
satility indices were measured off-line. FD was considered
present when the ipsilateral ACA mean blood ﬂow velocity
was at least 30% greater than that of the contralateral ACA
[20,22]. All TCD studies and measurements were attended
by an experienced sonographer (DQ) who remained blind to
CT and MR imaging data. Baseline measurements and ves-
sel segment insonation were checked where appropriate by
another experienced sonographer (CRL).
Middle cerebral artery TCD monitoring and
recanalization characteristicsUnilateral TCD monitoring was also performed using the
digital power-motion Doppler unit (PMD 100, Spencer
Technologies) with a 2-MHz pulsed wave transducer ﬁxed
in place using the Spencer Marc series head frame. The
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onitoring protocol was as follows: after determining TIBI
rade of 3 or less, the sample volume length was set at
0mm and insonation depth set immediately distal at the
ite of the commencement of attenuation in MCA waveform.
ower output was set at the maximum permitted level;
onitoring commenced immediately after commencement
f intravenous thrombolysis and continued for 2 h. Contin-
ous off-line review of recanalization status was performed
y an experienced neurosonologist (HZ) and documentation
f TIBI grades made a 5 minutely intervals through the 2 h
onitoring period. Sudden major improvement in TIBI grade
as deﬁned as increase of ≥3 TIBI grades in <15min. Full
ecanalization was deﬁned as achievement of TIBI grades 4
r 5. All TCD analyses were performed blind to CT and MR
maging analyses.
MES were counted at off-line review of the by consen-
us human expert assessment (HZ and CRL) using standard
coustic and spectral criteria and also using PMD TCD criteria
nd related embolic signatures [28,29].
rain imaging
T scans were obtained with a multidetector scanner (16-
lice Philips Mx8000). Whole brain noncontrast CT was
erformed: 120 kV, 170mA, 2 s scan time, contiguous 6-mm
xial slices. Perfusion CT (CTP) followed, comprising two
0-s series. Each series consisted of one image per slice per
econd, commencing 5 s after intravenous administration of
0ml of non-ionic iodinated contrast at a rate of 5ml/s via
power injector. Each perfusion series covers a 24mm axial
ection acquired as two adjacent 12-mm slices. The ﬁrst sec-
ion was at the level of the basal ganglia/internal capsule,
nd the second was placed directly above, towards the ver-
ex. Thus, the two perfusion CT series allows assessment of
wo adjacent 24mm cerebral sections [30].
T angiography
TA was performed after CTP, using the parameters 120 kV,
25mA, slice thickness 1.5mm, pitch 1.5:1, helical scan-
ing mode, intravenous administration of 70ml of non-ionic
ontrast at 4ml/s. Bolus-tracking software was used to
aximise image acquisition at peak contrast arrival. Data
cquisition was from base of skull to the top of lateral
entricles. Patients were selected if complete occlusion on
TA was present. Contrast within the distal MCA (beyond
he occlusion) was presumed secondary to retrograde ﬁlling
ia leptomeningeal collaterals. Collateral status was divided
nto ‘‘good’’, ‘‘moderate’’ or ‘‘poor’’ based on degree of
econstitution of the MCA up to the distal end of its occlu-
ion on CTA [16]. Moderate ﬂow and poor collateral ﬂow
ere graded together as ‘‘reduced’’.
RIollow-up imaging used a 1.5 T MRI (Siemens Avanto). The
troke MRI protocol included an axial spin-echo T2-weighted
eries, an axial isotropic diffusion-weighted echoplanar
pin-echo sequence (DWI), time of ﬂight MR angiography
1 C. Levi et al.
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Results
Among 90 consecutive patients assessed for intravenous
thrombolysis eligibility within 6 h of stroke onset, 53 (42
of whom received thrombolytic therapy) were included
in the analysis for ACA FD. A subgroup of 27 patients
with MCA occlusion treated with intravenous thrombolysis
was included in the analysis of recanalization character-
istics. Patients were excluded due to lack of evidence of
ICA or MCA occlusion on CTA [17], absence of temporal
windows [11], incomplete or poor quality CTA [4], PCA occlu-
sion [1] or aplastic or hypoplastic ACA [3], and non-stroke
[1]. Occlusion site was determined by CTA and included
42 M1/M2 occlusions and 11 intracranial ICA occlusions.
Baseline characteristics of the main sample and MCA throm-
bolysis subgroup are shown in Tables 1 and 2.
Flow diversion
Signiﬁcant FD to the ACA was present in 24/53 (45%) patients
and to the PCA in 8/38 (21%) patients. Because adequate
insonation of both PCAs was not possible in 15/53 (28%) of
patients, further analysis of PCA FD was not undertaken. The
differences in admission and outcome variables between
groups deﬁned by the presence or absence of FD are dis-
played in Table 3.
The presence of ACA FD was strongly associated with a
CTA good collateral ﬂow grade; 18 of 23 (78%) with good CTA
collaterals had an ACA ratio greater than 1.3. However, 23
of 26 (88%) with reduced CTA collaterals had an ACA FD ratio
less than 1.3 (Odds ratio 27.6, p < 0.001).
Twenty-four hour core infarct expansion ( core >5ml
between baseline and 24 h imaging) was also strongly
Table 1 Baseline characteristics of all patients presenting
with acute anterior circulation ischemic stroke studied with
TCD (n = 53).
Variables
Age, yearsa 72 (65—79)
Male genderb 30 (56.6)
Admission National Institution Health
Stroke Score; mean (SD)
17 (4.9)
History of hypertensionb 39 (74)
Atrial ﬁbrillation by history or ECGb 22 (42)
History of myocardial infarction or
ischemic heart diseaseb
23 (43)
History of previous strokeb 13 (25)
History of diabetes mellitusb 8 (15)
Current smokingb 8 (15)
Time from symptom onset to hospital
arrival in minutesa
79 (60—114)
Time from hospital arrival to CT in
minutesa
32 (20—50)88
MRA), and perfusion-weighted imaging (PWI) with an axial
2*-weighted echoplanar sequence [31].
ssessment of perfusion lesions and ﬁnal infarct
olumes
e-identiﬁed CTP and perfusion MR data were analysed with
IStar software using an identical deconvolution algorithm
o generate both CTP and MR perfusion maps, including
ean transit time (MTT) and cerebral blood volume (CBV)
30,31]. A MTT delay of >145% compared with the contra-
ateral hemisphere was used to calculate automated CTP
TT lesion volumes [32]. Within the CTP MTT lesion, base-
ine infarct core volume was determined from CBF maps
sing an automated threshold of <40% normal tissue [5].
hus, penumbral volume was determined from the differ-
nce between the baseline CTP MTT lesion and CBF lesions,
nd the ‘‘CTP mismatch’’ ratio was calculated from MTT
esion volume/CBF lesion volume (using the above thresh-
lds for MTT and CBF lesion volumes). The same software
as used to measure 24 h infarct volume using automated
ignal intensity thresholds for MR-DWI, or Hounsﬁeld unit
hresholds for CT [31]. The follow-up infarct maps were co-
egistered with baseline CTP maps to obtain volumes from
he same spatial position and axis orientation. To determine
eperfusion, the automated threshold (MTT delay of >145%
ompared with contra-lateral hemisphere) was used to cal-
ulate 24 h MR (or CTP)-MTT lesion volumes. The MR-MTT
aps were co-registered with baseline CTP so that MR-MTT
olumes were obtained from the same spatial position and
xis orientation as the CTP-MTT maps. All lesion volumes
ere obtained from the average of measurements taken on
eparate occasions by a stroke neurologist and stroke fel-
ow. Reperfusion was deﬁned as ‘‘major’’ in patients with
80% reduction in baseline-24 h MTT lesion volume and/or
omplete vessel recanalization [30,31]. All imaging analyses
ere performed blind to TCD data.
During the study a subgroup of patients were included
n the randomised Tenecteplase in Stroke trial receiving
ither intravenous tenecteplase (0.1mg/kg or 0.25mg/kg
s a bolus dose) or standard alteplase therapy within 6 h of
ymptom onset [33].
tatistical analysis
tatistical analysis was performed using ‘‘Stata’’ (Ver-
ion 10, College Station, TX 2007). Statistical comparisons
etween patients with and without FD were performed for
he total sample (ICAOs and MCAOs, n = 53) as well as for
he MCAOs alone (n = 42). Comparisons between patients
ith major reperfusion and no reperfusion were made in
he subgroup pf patients with MCA occlusion treated with
ntravenous thrombolysis. Differences in continuous mea-
urements were tested using the Mann—Whitney U test and
ifferences in categorical outcomes were tested using the
isher’s exact test with two tailed p values. The impact of
D and TIBI grade on admission and 24 h perfusion lesions,
nfarct volumes and clinical outcome was examined using
egression analyses to adjust for potential confounding fac-
ors.
Time from CT to transcranial Doppler
ultrasound in minutesa
44 (27—52)
a Median (IQR) values.
b Values are n (%); SD, standard deviation.
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Table 2 MCAO thrombolysis subgroup — baseline characteristics by 24 h reperfusion status.
Baseline characteristics Major reperfusion
n = 16
Non-reperfusion
n = 11
p
Mean age 71 years SD 18.1 55.7 SD 19.1 p = 0.02
Female 56% 33%
Mean NIHSS 15.8 SD 5.1 18.2 SD 3.7 p = 0.18
Median infarct core volume 17.6ml Range: 0.4—88.8 34.4ml Range: 0.4—77ml p = 0.15
Median perfusion lesion volume 110.6ml Range: 30.3—141.2 144ml Range: 59.1—169.8ml p = 0.007
Good collateral grade 50% 40% p = 0.30
ACA ﬂow diversion 44.40% 50% p = 0.80
Mean systolic BP 152mmHg SD 20.5 150.6mmHg SD 26.8
Mean diastolic BP 87mmHg SD 11.1 86.7mmHg SD 15.4
Risk factors
AF 50% 20%
HT 61% 60%
DM 11% 20%
HC 27% 50%
Current smoking 17% 20%
Antithrombotic medication (%)
Antiplatelet 27% 10%
a
v
a
aWarfarin 11%
associated with ACA FD where only 6 of 22 patients (27%)
with an ACA FD ratio of greater than 1.3 had infarct
core growth compared with 22 of 28 (78%) with ACA FD
ratios of less than 1.3 (Odds ratio 9.7, p < 0.001). The
presence of ACA FD may indicate a subgroup of patients
with better collateral ﬂow and a relatively stable ischemic
penumbra.
t
(
Table 3 Differences in admission and outcome variables between
ﬂow diversion (FD).
All patients (n = 53)
MCAO and ICAO (n = 53)
FD+
24
FD−
29
Good collaterals according to CTAb 21/24 (87.5) 6/29 (20
Admission NIHSSa 16 (12—18.5) 18 (16—2
Admission infarct core volumea 6.4 (4—15) 52.2 (26—
Admission penumbral volumea 95.3 (78—113) 65.5 (33—
Total perfusion lesiona 107.6 (87—130) 118 (85—
Mismatch ratioa 12.4 (8—27) 1.95 (1.8
Thrombolysisb 22/24 (91.7) 20/29 (6
Major recanalization/reperfusionb 16/23 (69.7) 16/29 (5
Infarct expansion (ml)a 2.3 (−0.5 to 15) 38 (9—69
Final infarct volume (ml)a 14 (7—25) 92 (46—1
24 h NIHSSa 4 (1—12) 17 (8—25
90 day mRS≤ 2b 18/24 (75.0) 6/29 (21
FD+, anterior cerebral artery ﬂow diversion positive; FD−, anterior cer
angiography; NIHSS, National Institute of Health Stroke Scale; mRS, mo
transit time lesion volume by cerebral blood volume lesion volume.
a Median (IQR) values.
b Values are n (%).0%
After adjusting for occlusion site, stroke onset time to CT,
ge and gender, the two predictors of baseline infarct core
olume on linear regression analysis were FD (p < 0.001) and
cute NIHSS (p = 0.002). Predictors of penumbral volume,
fter adjusting for occlusion site, acute NIHSS, onset time
o CT and gender, FD (p < 0.001) and younger age (p = 0.016)
r2 = 0.3707) remained signiﬁcant.
groups deﬁned by the presence or absence of TCD detected
MCAO only (n = 42)
p FD+
23
FD−
19
p
.7) <0.001 20/23 (87) 6/19 (32) <0.001
2) 0.024 16 (12—19) 17 (13—19) 0.454
80) <0.001 6.2 (4—16) 36.1 (21—58) 0.001
76) <0.001 93.9 (78—113) 69 (25—79) 0.002
146) 0.357 104 (86—131) 105 (48—142) 0.859
—3.4) <0.001 12.3 (7.5—27) 2.7 (1.9—4) <0.001
9) 0.086 21/23 (91) 17/19 (89) 1.000
5) 0.392 16/22 (73) 12/19 (63) 0.737
) 0.001 1.9 (−0.5 to 5) 23 (3—84) 0.006
42) <0.001 14 (7—20) 65 (25—143) <0.001
) <0.001 3 (1—12) 12 (4—19) 0.016
.7) <0.001 17/23 (74) 6/19 (32) 0.012
ebral artery ﬂow diversion negative; CTA, computed tomography
diﬁed Rankin score; mismatch ratio calculated by dividing mean
190 C. Levi et al.
Table 4 Predictors of favourable clinical outcome in patients following acute anterior circulation ischemic stroke.
Variable mRS 0—2
n (%)
Unadjusted analysis Adjusted analysis
(stepwise regression)
Odds ratio (CI) p value Odds ratio (CI) p value
Recanalization/reperfusion
No (n = 20) 3 (15.0) 1.00 1.00
Yes (n = 32) 21 (65.6) 10.3 (2.3—66.7) <0.001 21.1 (2.0—1208) 0.005
Flow diversion
No (n = 29) 6 (20.7) 1.00 1.00
Yes (n = 24) 18 (75.0) 10.8 (2.7—51.3) <0.001 27.5 (3.0—1451) <0.001
Age 0.98 (0.94—1.02) 0.385
Gender
Female (n = 23) 14 (60.9) 1.00
Male (n = 30) 10 (33.3) 0.33 (0.09—1.14) 0.085
Admission National Institute of Health
Stroke Scale score
0.78 (0.66—0.90) <0.001 0.83 (0.67—1.01) 0.061
Stroke onset time to thrombolysis 0.99 (0.98—1.00) 0.136
Stroke onset time to transcranial Doppler
ultrasound
1.00 (0.99—1.00) 0.685
Thrombolysis
No (n = 11) 1 (9.1) 1.00
Yes (n = 42) 23 (54.8) 11.6 (1.4—547.6) 0.014
Middle cerebral artery occlusion
No (n = 11) 0 (0.0) 1.00
Yes (n = 42) 24 (57.1) 18.9 (2.8—∞) <0.001
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oCI, conﬁdence interval (95%); mRS, modiﬁed Rankin score.
Predictors of 24 h infarct volume after adjusting for
cclusion site, therapy with thrombolytic agent, and
troke onset to thrombolytic treatment time were: FD
p < 0.001), major reperfusion (p < 0.001) and lower acute
IHSS (p = 0.02) (r2 = 0.6689).
Independent predictors of a favourable clinical outcome,
s measured by 90 day mRS 0—2, were FD (OR 27.5,
< 0.001), major reperfusion (OR 21.1, p = 0.005; Table 4).
ll patients with ICAO as the site of vessel occlusion had a
oor outcome.
ecanalization monitoring subgroup
he characteristics of the patients with MCA occlusion
reated with intravenous thrombolysis are shown in Table 2.
atients with major reperfusion post-thrombolysis were sig-
iﬁcantly older than those with non-reperfusion (71 years
s 56 years, p = 0.02); however, the major reperfusion
atients showed smaller perfusion lesion (111ml vs 144ml,
= 0.007) and a trend towards smaller infarct core volumes
18ml vs 34ml, p = 0.15) at baseline. TCD monitoring times
ere not signiﬁcantly different between groups (major
eperfusion, 103min; non-reperfusion, 124min; p = 0.34).
onsistent with other studies, patients with major reperfu-
ion showed smaller median 24 h infarct core volumes (28ml
s 46ml, p = 0.005), lower 24 h mean NIHSS score (12.1 vs
6.7, p = 0.009), and a higher proportion of patients with
avourable 90 day functional outcomes (mRS 0—2, 63% vs
0%, p = 0.002).
The TIBI grade proﬁles for each case is shown in Fig. 1A
nd B. Major TIBI grade change (improvement by ≥3 grades
s
O
t
iuring the post-thrombolysis monitoring period) was associ-
ted withmajor reperfusion (p = 0.04) along with higher odds
f attenuation of infarct core growth (p = 0.06), improve-
ent in NIHSS score (p = 0.049) and excellent 90 day
unctional outcome (mRS 0—1; p = 0.03). Major sudden TIBI
rade change (improvement of ≥3 grades over ≤15min) was
ssociated with a trend towards excellent functional out-
ome (mRS 0—1; p = 0.09).
MES were detected in 36% proportion of cases over-
ll, 37% in the patients with major reperfusion and 33% in
atients with non-reperfusion (p = 0.55). There was no asso-
iation between the presence of microemboli and major
IBI grade change, 24 h infarct core volume or clinical
utcomes.
iscussion
his is the ﬁrst description of the relationship between
CD features of leptomeningeal collateralisation and
ecanalization, hyperacute brain perfusion status, and their
elationships to tissue fate and clinical outcomes in acute
schemic stroke. Our data demonstrate that the ACA FD is
ssociated with improved LMC and is independently associ-
ted with 24 h infarct volume and 90 day clinical outcome in
cute anterior circulation stroke patients with identiﬁable
arge artery occlusion. ACA FD may therefore deﬁne a group
f patients who have a greater tolerance to ICA or MCA occlu-
ion and, potentially, a longer-lived ischemic penumbra.
ur data also demonstrate that in MCA occlusion patients
reated with intravenous thrombolysis, major improvement
n TIBI grade is associated with major reperfusion at 24 h
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Figure 1 Comparison of TIBI grade change over time post
intravenous thrombolysis between patients with major reperfu-
sion (A) and non-reperfusion (B). Reperfusion measured at 24 h
post intravenous thrombolysis using MR perfusion. Major reper-
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along with improved 24 h and 90 day clinical outcome and
a trend towards less infarct core growth.
Flow diversion
Although deﬁnitions and indices of ACA ﬂow diversion vary in
the literature [17,20—23] the ACA asymmetry index used by
Zanette [20], based on comparison between digital cerebral
angiography and TCD performed within 6 h of stroke onset, is
likely to be the most reliable and easily applicable measure
in hyperacute stroke. The same asymmetry index was used
to deﬁne TCD FD in the retrospective analysis of the CLOT-
BUST trial. In this study, FD was observed in 83% of patients
with MCAO treated with tissue plasminogen activator ther-
apy. This patient population excluded cases with ICAO and
also those cases with early TCD measured recanalization,
but noted that FD was associated with early neurological
improvement [23]. To date no other published acute stroke
studies have correlated TCD FD with CT angiographic mea-
sures of collateral ﬂow, nor have examined associations with
perfusion lesion volumes and long-term functional outcome.
We did not ﬁnd any signiﬁcant association between the
presence of FD and the total volume of the perfusion lesion
despite the admission NIHSS being lower in patients with
ACA FD. In contrast, we demonstrated a strong and inde-
pendent association between FD and the volume of the CTP
deﬁned infarct core. This ﬁnding suggests the importance
w
i
1
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f collateral ﬂow and its TCD correlate in predicting acute
nfarct volume [34] and clinical outcome.
Patients with ICA occlusion are more likely to have com-
romised ACA collateral ﬂow. This was demonstrated in the
esults, where, 55% of patients with combined ICA +MCA
cclusion showed no FD as opposed to 42% of patients with
CA occlusion showing no FD (derived from Table 2).
When accompanied by major reperfusion, FD signiﬁcantly
ncreased the chances of a favourable outcome in keeping
ith other reports of a potential synergistic effect between
MC and major reperfusion [12,16]. In our study, 43% of FD
ositive patients who did not undergo major reperfusion had
favourable outcome suggesting that LMCs are capable, in
ome patients, of perfusing the territory of an occluded
rtery to a level sufﬁcient to avoid infarction even with-
ut complete recanalization [11], ACA FD therefore appears
o be a rapid onset internal protection mechanism for the
schemic area, mitigating infarct core expansion.
ecanalization monitoring
CD is recognised to accurately reﬂect recanalization status
f the MCA when compared to catheter angiography [35]
nd TCD deﬁned TIBI recanalization grades recognised
o correlate with baseline stroke severity and clinical
ecovery [36]. There is, however, limited data describing
ecanalization characteristics in the initial hours following
cute MCA stroke and no data correlating TCD recanaliza-
ion characteristics with reperfusion status and the extent
f early infarction. Alexandrov et al. [37] described a cohort
f 65 patients treated with intravenous tissue plasminogen
ctivator within 3 h of stroke onset and monitored with
CD post-thrombolysis. Similar to our ﬁndings, major
mprovements in TIBI grades (in this study over time periods
f less than 30min) were associated with signiﬁcantly
ower 24 h post-thrombolysis NIHSS. Using transcranial
olour coded duplex (TCCD) the Duplex Sonography in
cute Stroke Study group performed TCCD 30min and 6 h
ost-thrombolysis in patients with a variety of ICA and MCA
cclusion patterns [38]. In this patient group, cases showing
ecanalization assessed by TIBI grade change also showed
igniﬁcant improvements in 24 h NIHSS when compared to
hose without TCCD features of recanalization.
Studies examining use of transcranial ultrasound in guid-
ng clinical decision in acute stroke are also limited. In the
mall sample of patients entered into the Intervention Man-
gement of Stroke (IMS) trial, MCA blood ﬂow velocity ratios
omparing the affected to unaffected artery accurately
dentiﬁed angiographic lesions amenable to endovascular
herapy [39]. The clinical relevance and application of this
nding are uncertain.
We have identiﬁed only one study evaluating the use
f TCCD as a decision-assistance aid in identifying intra-
enous thrombolysis treated patients who require triage
o endovascular reperfusion therapy. Sekoranja et al. [40]
xamined patients treated with intravenous thrombolysis
or MCA occlusion (TIBI grade 0—3 at baseline) monitored
ith intermittent TCCD. At 30min post-commencement of
ntravenous thrombolysis, lack of improvement by at least
TIBI grade was used to shift management to endovascu-
ar management. Although uncontrolled, the study showed
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hat favourable long-term outcome (mRS 0—2) was achieved
n the acceptable proportions of patients (59%) where intra-
enous therapy alone was continued. This assuming a TIBI
rade of at least 3 was achieved at 30min post-intravenous
hrombolysis. For those patients triaged to endovascular
herapy on the basis of lack of any TIBI improvement
t 30min, 56% of patients had a favourable long-term
utcome.
MES were commonly detected during the process of
ecanalization; however, in this relatively small sample of
atients, the occurrence of MES did not associate with more
ffective reperfusion, 24 h infarct volumes neither improved
arly nor improved late clinical outcomes.
onclusion
he growth in endovascular reperfusion therapy options in
cute stroke is driving a need for more sophisticated imag-
ng approaches to gauge both the time-frame of survival of
he ischemic penumbra and the effectiveness of ‘‘ﬁrst-line’’
ntravenous thrombolytic therapies. In MCA stroke the use
f TCD to gauge the adequacy of collateral ﬂow and the
ffectiveness of thrombolysis-induced recanalization holds
romise as a clinically useful test. Further validation is
eeded through both observational studies using both clini-
al and imaging outcome measures and ideally, randomised
tudies evaluating TCD-guided decision assistance.
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